PaxMedica Stock Price, News & Analysis
Company Description
PaxMedica (OTC Link: PXMD) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $2.8M, ranking #6,918 among all listed U.S. companies by market cap.
PXMD stock has gained 150.0% over the past year. Shares last traded at $0.0005.
On a trailing twelve-month basis, PaxMedica reported revenue of $0 with net income of -$18.3M and diluted earnings per share of $-11.00.
This page provides a comprehensive overview of PXMD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
PaxMedica (PXMD) stock last traded at $0.0005. Over the past 12 months, the stock has gained 150.0%. At a market capitalization of $2.8M, PXMD is classified as a micro-cap stock with approximately 126.3M shares outstanding.
Latest News
PaxMedica has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include offering, fda approval. View all PXMD news →
SEC Filings
PaxMedica has filed 1 recent SEC filing, including 1 Form 10-Q. The most recent filing was submitted on January 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PXMD SEC filings →
Financial Highlights
operating income reached -$16.1M, and net income was -$18.3M. Diluted earnings per share stood at $-11.00. The company generated -$10.8M in operating cash flow. With a current ratio of 3.16, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in PaxMedica (PXMD) currently stands at 687 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for PaxMedica (PXMD) currently stands at 1.4 days, up 42% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 42% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.5 days.
PXMD Company Profile & Sector Positioning
PaxMedica (PXMD) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the OTC Link.
Investors comparing PXMD often look at related companies in the same sector, including Biostax Corp (BTAX), Aridis Pharmaceuticals Inc (ARDS), Navidea Biopharm (NAVB), Virpax Pharmaceuticals Inc (VRPX), and Syros Pharmaceut (SYRS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PXMD's relative position within its industry.